Trials / Sponsors / Restorbio Inc.
Restorbio Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults Covid19 | Phase 2 | 2020-10-13 |
| Terminated | Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Home COVID19 | Phase 2 | 2020-07-11 |
| Withdrawn | Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly Clinically Symptomatic Respiratory Illness | Phase 3 | 2019-10-21 |
| Completed | A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly Respiratory Tract Infections | Phase 3 | 2019-04-15 |
| Active Not Recruiting | Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respi Respiratory Tract Infections | Phase 2 | 2017-11-15 |